Supporting this idea, we found that podocyte ANGPTL4 was significantly reduced following exposure to serum obtained during and after vincristine treatment and increased levels of this factor are associated with proteinuria in patients with diabetic nephropathy,56 SRNS,39 and membranous nephropathy.57 The gene discussed is ANGPTL4; the disease is diabetic kidney disease.